Q4 2025 Holdings
Filed 2026-02-13 | 48 holdings | $172.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $29.7M | 100,781 | 17.2% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $23.9M | 108,404 | 13.9% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $15.1M | 2,834,652 | 8.8% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $11.4M | 8,753,290 | 6.6% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $9.2M | 522,305 | 5.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $9.0M | 67,000 | 5.2% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $8.7M | 506,754 | 5.0% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $5.5M | 151,000 | 3.2% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $5.0M | 74,687 | 2.9% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $4.9M | 2,668,395 | 2.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $4.8M | 263,642 | 2.8% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $4.5M | 1,210,000 | 2.6% |
| Verrica Pharmaceuticals Inc(VRCA) | COM SHS | 92511W207 | $3.9M | 471,559 | 2.3% |
| Inspiremd Inc(NSPR) | COM | 45779A846 | $3.8M | 2,143,698 | 2.2% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $3.7M | 108,000 | 2.1% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $3.6M | 312,000 | 2.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $2.8M | 70,000 | 1.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.7M | 130,000 | 1.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.7M | 86,500 | 1.6% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $2.7M | 352,000 | 1.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $2.6M | 205,000 | 1.5% |
| Profound MED Corp(PROF) | COM NEW | 74319B502 | $2.2M | 285,710 | 1.3% |
| Kazia Therapeutics LTD | SPONSORED ADS | 48669G303 | $2.1M | 300,000 | 1.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.8M | 750,000 | 1.0% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $1.0M | 83,333 | 0.6% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $976.3K | 687,500 | 0.6% |
| Trevi Therapeutics IncCall | CALL | 89532M901 | $482.0K | 38,500 | 0.3% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $431.5K | 6,500 | 0.3% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $361.2K | 40,000 | 0.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $340.8K | 80,000 | 0.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $323.2K | 3,700 | 0.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $303.5K | 16,000 | 0.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $260.8K | 160,000 | 0.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $217.0K | 70,000 | 0.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $214.8K | 10,000 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $187.6K | 20,000 | 0.1% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $183.1K | 35,000 | 0.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $147.0K | 100,000 | 0.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $145.8K | 15,000 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $125.7K | 33,000 | 0.1% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $108.8K | 170,000 | 0.1% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $105.8K | 13,000 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $90.9K | 45,000 | 0.1% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $83.2K | 20,000 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $46.0K | 40,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $43.8K | 35,000 | 0.0% |